Circio raises NOK 10.7 million in upsized offering from new and existing shareholders
· Circio has raised a total of approx. NOK 10.7 million in new capital from the exercise of warrants and a private placement carried out on 18 December 2024 · Applications for allocation of available warrants were 3 times oversubscribed · The shareholder base has been strengthened by the addition of two new experienced biotech investorsOslo, Norway 18 December 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing powerful circular RNA technology for next generation nucleic acid medicine, today announces that it has secured approx. NOK 10.7 million in financing to